Interaction of adenosine and prostacyclin in coronary flow regulation after myocardial ischemia

Citation
V. Stangl et al., Interaction of adenosine and prostacyclin in coronary flow regulation after myocardial ischemia, EUR J PHARM, 377(1), 1999, pp. 43-50
Citations number
20
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN journal
00142999 → ACNP
Volume
377
Issue
1
Year of publication
1999
Pages
43 - 50
Database
ISI
SICI code
0014-2999(19990714)377:1<43:IOAAPI>2.0.ZU;2-5
Abstract
The role of adenosine and prostacyclin in post-ischemic vasodilation was in vestigated using a model of sequential perfusion of two isolated hearts. Tw o guinea pig hearts were sequentially perfused (10 ml/min) without (control , n = 4) or with preceding 10-min ischemia (n = 6) of Heart I. Under contro l conditions no hemodynamic changes were observed in Heart II during sequen tial perfusion. After 10 min of ischemia of Heart I coronary perfusion pres sure decreased by 23% in Heart IT at the onset of sequential perfusion. Ade nosine A(1) and A(2) receptor antagonists 1,3-dipropyl-8-cyclopentylxanthin e (DPCPX) (2 mu M) and 3,7-dimethyl-1-propargylxanthine (DMPX) (20 mu M) in fused simultaneously inhibited this decrease in coronary perfusion pressure by 74%, whereas indomethacin (5 mu M) had no effect. DPCPX, DMPX and indom ethacin in combination induced a significant increase in coronary perfusion pressure. Adenosine release (HPLC) into the coronary effluent after ischem ia was significantly enhanced in the presence of indomethacin. These result s suggest that after myocardial ischemia prostacyclin has an inhibitory eff ect on adenosine release. (C) 1999 Elsevier Science B.V. All rights reserve d.